MiR-196b-5p stimulates stemness and 5-FU-chemoresistance of CRC cells, giving rise to activation of STAT3 signaling by targeting negative regulators of the pathway such as SOCS1 and SOCS3 [199]. This evidence concerns the gene STAT3 and colorectal carcinoma.